Christian M. Tegeler

Phase I/II trial of a peptide-based COVID-19 T-cell activator in patients with B-cell deficiency

Jonas S. Heitmann, Claudia Tandler, Maddalena Marconato et al. · Nature Communications · 2023 · 35 citations · Full text

Life Sciences, Immunology, Pharmacology +17

The Clinical Relevance of the NATALEE Study: Application of the NATALEE Criteria to a Real-World Cohort from Two Large German Breast Cancer Centers

Henning Schäffler, Franziska Mergel, Kerstin Pfister et al. · International Journal of Molecular Sciences · 2023 · 34 citations · Full text

Medicine, Endocrinology, Oncology +17

The efficacy of sacituzumab govitecan and trastuzumab deruxtecan on stable and active brain metastases in metastatic breast cancer patients—a multicenter real-world analysis

Dominik Dannehl, Dominik A. Jakob, Franziska Mergel et al. · ESMO Open · 2024 · 28 citations · Full text

Medicine, Oncology, Pharmacology +13

Which Patients Do We Need to Test for BRCA1/2 Mutation? Feasibility of Adjuvant Olaparib Treatment in Early Breast Cancer–Real-World Data from Two Large German Breast Centers

Dominik Dannehl, Tobias Engler, Léa Louise Volmer et al. · Cancers · 2023 · 15 citations · Full text

Medicine, Genetics, Oncology +17

Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults

Claudia Tandler, Jonas S. Heitmann, Tanja Michel et al. · International Journal of Infectious Diseases · 2023 · 15 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17